Top Undervalued Stocks To Buy Right Now


We continue to believe that the pharmaceutical industry is selling at an undervalued price. In the semi-annual report, we detailed why we thought it was cheap. We wrote the following:

“As if Valeant (NYSE:VRX) has not given enough pain and anguish to our unitholders, we believepharmaceutical stocks as a group are selling at attractive valuations. They generate their earnings in cash and most of them are selling at less than 10 times cash earnings. Some of them are down more than 50% from their highs, which is what caught our attention initially. It may look like we are adding more emotional fuel to the fire from our experience with Valeant but we look at mispriced stocks on a case-by-case basis. Given our current favorable view of the pharmaceutical industry generally, as next discussed in greater detail, we expect to invest in stocks of more than two or more pharmaceutical companies (that is, to utilize a so-called “basket approach”), in order to reduce the potential adverse effect on fund returns that could result from Food and Drug Administration (FDA) approval and patent expiration issues faced by a single company.

Top Undervalued Stocks To Buy Right Now: MetLife, Inc.(MET)


Advisors’ Opinion:

  • [By Joseph Griffin]

    Flippin Bruce & Porter Inc. grew its position in MetLife (NYSE:MET) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 191,498 shares of the financial services provider’s stock after buying an additional 2,568 shares during the quarter. MetLife accounts for 1.9% of Flippin Bruce & Porter Inc.’s holdings, making the stock its 20th largest holding. Flippin Bruce & Porter Inc.’s holdings in MetLife were worth $8,788,000 at the end of the most recent quarter.

  • [By ]

    The Evercore analysts also said that Metlife Inc. (MET) and CNO Financial Group Inc. (CNO) have “sizable exposure” to long-term care from a reserve standpoint, “but our analysis indicates that their blocks have below average risk and/or more robust reserves versus peers, implying a lower risk of charges over the next few years.”

  • [By Ethan Ryder]

    Here are some of the news headlines that may have impacted Accern Sentiment’s analysis:

    Get MetLife alerts:


    Ultimate Stock-Pickers: Top 10 Buys and Sells (finance.yahoo.com) MetLife: Why investors should pay close attention to the… (finance.yahoo.com) Goldman Sachs Group Lowers MetLife (MET) to Neutral (americanbankingnews.com) Review: Morgan Wallen rocks MetLife Stadium, opens for Luke Bryan (digitaljournal.com) Goldman Sachs Downgrades MetLife (MET) to Neutral (streetinsider.com)

    Several equities research analysts recently issued reports on MET shares. Zacks Investment Research downgraded shares of MetLife from a “hold” rating to a “sell” rating in a research note on Tuesday, March 20th. Bank of America started coverage on shares of MetLife in a research note on Monday, March 26th. They set a “neutral” rating and a $50.00 price target on the stock. Atlantic Securities raised shares of MetLife from a “neutral” rating to an “overweight” rating in a research note on Monday, March 26th. Wells Fargo & Co reaffirmed a “buy” rating and set a $60.00 price target on shares of MetLife in a research note on Thursday, March 1st. Finally, Morgan Stanley dropped their price target on shares of MetLife from $58.00 to $56.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 5th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $56.81.

Top Undervalued Stocks To Buy Right Now: Tidewater Inc.(TDW)


Advisors’ Opinion:

  • [By Motley Fool Staff]

    Tidewater (NYSE:TDW) Q1 2018 Earnings Conference CallMay. 15, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    News headlines about Tidewater (NYSE:TDW) have been trending somewhat positive on Monday, Accern reports. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Tidewater earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave headlines about the oil and gas company an impact score of 45.9223416083374 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top Undervalued Stocks To Buy Right Now: Sherwin-Williams Company (SHW)


Advisors’ Opinion:

  • [By Joe Tenebruso]

    Shares of The Home Depot (NYSE:HD) and Sherwin-Williams (NYSE:SHW) have both crushed the market over the past decade, helping investors earn fortunes along the way.

  • [By Motley Fool Staff]

    Sherwin-Williams (NYSE:SHW) Q1 2018 Earnings Conference CallApril 24, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Demitrios Kalogeropoulos]

    Today, I’m taking a look at three of the biggest outperformers in the period –Sherwin Williams (NYSE:SHW), lululemon atheletica(NASDAQ:LULU), and MercadoLibre(NASDAQ:MELI)– which each grew by at least 700% over the past decade.

Top Undervalued Stocks To Buy Right Now: MarketAxess Holdings, Inc.(MKTX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Polen Capital Management LLC grew its holdings in MarketAxess Holdings, Inc. (NASDAQ:MKTX) by 42.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,852 shares of the financial services provider’s stock after purchasing an additional 552 shares during the period. Polen Capital Management LLC’s holdings in MarketAxess were worth $403,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    MarketAxess (NASDAQ: MKTX) and Gleacher & Co. Ltd. (OTCMKTS:GLCH) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Leave a Reply

Your email address will not be published.